Investigation of Psycho-Physiological Parameters in Adolescent Inpatients With Anorexia Nervosa

Adolescent Inpatients With Anorexia Nervosa: Changes in Heart Rate Variability, Body Warmth and Eating Disorder Features - a Prospective Controlled Study

A study to assess changes in mental and physical symptoms in adolescent inpatients with anorexia nervosa, a severe eating disorder.

Study Overview

Status

Completed

Conditions

Detailed Description

This is a prospective controlled trial to assess changes in psycho-physiological parameters, including eating disorder features (drive for thinness, body dissatisfaction) and comorbid symptoms such as anxiety, depression and quality of life as well as heart rate variability, body warmth and BMI in adolescent inpatients with anorexia nervosa. Parameters were assessed at admission, six weeks after admission and three months thereafter and compared to reference values of healthy controls.

Study Type

Observational

Enrollment (Actual)

80

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Baden-Württemberg
      • Filderstadt, Baden-Württemberg, Germany, 70794
        • Die Filderklinik

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

9 years to 16 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Adolescent patients with Anorexia Nervosa who are admitted to the Filderklinik's ward for eating disorders to attend a specific inpatient treatment program based on anthroposophic medicine

Description

Inclusion Criteria:

  • Age 11-18 years
  • Restrictive subtype of adolescent AN
  • Fulfilling the AN diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV and V)
  • Admitted to the Filderklinik for inpatient treatment

Exclusion Criteria:

  • Patients diagnosed with the binge-purge subtype of adolescent AN or with other eating disorders
  • Healthy controls: BMI beyond the defined norm for their age group
  • Healthy controls: acute or chronic disorders including psychiatric disorders, heart defects, cardiac arrhythmia, other disorders requiring medication

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Multimodal treatment for AN
Adolescent patients with AN attending an integrative medicine-based inpatient treatment program
Multimodal inpatient treatment program based on anthroposophic medicine, including individual and group psychotherapy, family therapy, art therapies and specific nursing applications such as embrocations, rhythmical massage and oil dispersion baths.
Healthy controls
Healthy volunteers assessed once to collect comparative data

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Drive for Thinness
Time Frame: At admission (timepoint 1, t1), six weeks after admission (t2), and three months after t2 (t3)
Assessed with the 7-item subscale Drive for Thinness of the self-reporting Eating Disorder Inventory-2 at admission to the hospital (t1), six weeks after admission (t2) and three months after t2 (t3)
At admission (timepoint 1, t1), six weeks after admission (t2), and three months after t2 (t3)
Change in Body Dissatisfaction
Time Frame: At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
Assessed with the 9-item subscale Body Dissatisfaction of the self-reporting Eating Disorder Inventory-2 at admission to the hospital (t1), six weeks after admission (t2) and three months after t2 (t3)
At admission (t1), six weeks after admission (t2), and three months after t2 (t3)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anxiety
Time Frame: At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
Assessed with the 7-item subscale Anxiety of the self-reporting Hospital Anxiety and Depression Scale at admission to the hospital (t1), six weeks after admission (t2) and three months after t2 (t3)
At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
Depression
Time Frame: At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
Assessed with the 7-item subscale Depression of the self-reporting Hospital Anxiety and Depression Scale at admission to the hospital (t1), six weeks after admission (t2) and three months after t2 (t3)
At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
SF-12 physical
Time Frame: At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
Physical health-related quality of life, assessed with the 6-item subscale Physical Health of the self-reporting Health-Related Quality of Life Questionnaire (SF-12) at admission to the hospital (t1), six weeks after admission (t2) and three months after t2 (t3)
At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
SF-12 mental
Time Frame: At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
Mental health-related quality of life, assessed with the 6-item subscale Mental Health of the self-reporting Health-Related Quality of Life Questionnaire (SF-12) at admission to the hospital (t1), six weeks after admission (t2) and three months after t2 (t3)
At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
SF-12 global
Time Frame: At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
Overall health-related quality of life, assessed with the self-reporting 12-item Health-Related Quality of Life Questionnaire (SF-12 sum-score) at admission to the hospital (t1), six weeks after admission (t2) and three months after t2 (t3)
At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
Weight gain
Time Frame: At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
Change in BMI (kg/m2) based on body weight measurements taken at admission to the hospital (t1), six weeks after admission (t2) and three months after t2 (t3)
At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
Heart rate
Time Frame: At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
Heart rate (beats/min), derived from 24h ECG recordings
At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
Heart rate variability: SDNN
Time Frame: At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
Standard deviation of normal to normal (NN) intervals (ms), derived from 24h ECG recordings
At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
Body warmth
Time Frame: At admission (t1), six weeks after admission (t2), and three months after t2 (t3)
Body surface temperature (°C) at the inner canthi of both eyes, measured with high-resolution infrared thermography at admission (t1), six weeks after admission (t2) and three months after t2 (t3)
At admission (t1), six weeks after admission (t2), and three months after t2 (t3)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2013

Primary Completion (Actual)

October 9, 2014

Study Completion (Actual)

October 9, 2014

Study Registration Dates

First Submitted

September 5, 2019

First Submitted That Met QC Criteria

September 9, 2019

First Posted (Actual)

September 10, 2019

Study Record Updates

Last Update Posted (Actual)

September 10, 2019

Last Update Submitted That Met QC Criteria

September 9, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anorexia Nervosa

Clinical Trials on Integrative medicine-based multimodal treatment

3
Subscribe